Close Menu

Nobel Prize-winning scientist Paul Greengard has discovered a new way for researchers to target Alzheimer's disease. Beta amyloid, the plaque that builds up in the brains of Alzheimer's patients, has long been targeted by researchers. Now Greengard has discovered a new protein that is needed to make beta amyloid, reports the New York Times' Gina Kolata. Many Alzheimer's drugs currently being studied target the enzyme gamma secretase, which helps make beta amyloid.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Oil made from gene-edited soybeans is already in use, according to the Associated Press.

USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.

Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.

In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.